Unlock the new era of precision health with our whole genome platform.
WHOLE GENOME SEQUENCING COMPANY
Inocras is an AI-driven platform company providing whole genome insights to enable personalized care in cancer and rare diseases.
Founded in 2020 by a team of physician-scientists, geneticists, and bioinformaticians, our goal has been to improve how patients are diagnosed and treated by unlocking the full potential of genomic data. Since then, we’ve developed an IP-protected technology and proprietary whole genome insight platform while achieving operational excellence in our CLIA certified and CAP accredited lab.
We are also bringing innovation in delivery through patient-centric services that provide access to genetic counseling and clinical trial matching support.
We believe that genomic information should be accessible to everyone. By breaking down technology and cost barriers, we are paving the way for a future where genomic data drives targeted treatments and fuels healthier lives.
We are fueled by our core values of patient-centricity, empowerment, innovation, and collaboration at the heart of everything we do.
When it comes to your health, or that of your loved ones, exploring all possible options is essential. Our whole genome diagnostic testing is designed to uncover broader and deeper insights that other DNA tests might miss.
At Inocras, our goal is to help relieve your diagnostic burden so you can spend more time caring for your patients. Our whole genome platform provides you with additional data, tools, and confidence to support your best medical decision-making. Partnering with Inocras gives you cutting-edge sequencing services and genomics services to enhance human health and streamline your clinical practice.
Maximize your research potential with precision DNA sequencing, curation, and interpretation.We provide our services at affordable prices thanks to high-level automation in our bioinformatics pipeline and high-throughput sequencing technology. Unlock the full potential of your research – reliably in 2 weeks. Partner with one of the leading sequencing companies to elevate your research to the next level.
We are a global team with a shared goal: Delivering impact to patients and the healthcare industry through actionable insights and user-centric services.
Chief Executive Officer
Co-founder, Director of Genome Insight Institute, M.D., Ph.D
Co-founder, Chief Innovation Officer, M.D., Ph.D.
Chief Strategy Officer
Chief Technology Officer, M.D., Ph.D
Chief Medical Officer, Ph.D
Chief Product Officer, M.D.
Chief Clinical Operations Officer